“…Along with their role as molecular sensors in the nociceptive pathway, evidence indicates that TRPV1 channels have a broad physiological function, underscoring their importance in pharmacology and biomedicine. , In contrast to commercially available drugs targeting the inflammatory system, TRPV1 antagonists act as critical negative modulators of nociceptive transduction . Moreover, TRPV1 activation is followed by nerve inactivation, ,, making both potent agonists and antagonists viable tools to promote the desired analgesic effect, provided the necessary pharmacokinetic characteristics are favorable. , In this context, the naturally occurring molecules capsaicin (CAP) and resiniferatoxin (RTx) are well-described vanilloid ligands acting as potent TRPV1 agonists. ,− On the other hand, capsazepine (CPZ), a synthetic derivative of CAP, is an inhibitor of TRPV1 activity. , All three have inhibited nociceptive neuron firing in vitro and in vivo . − Thus, targeting TRPV1 channel activity presents an attractive approach to pain relief that may qualify as the next generation of analgesics. ,, …”